SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Histogen, Inc., a regenerative medicine company focused on stimulating the body's stem cells to regenerate tissues, announced today that it will be featured as a presenting company at the 21st Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on

STRASBOURG, France, Sept. 3, 2019 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced the appointment of David Garrett, MBA, CPA, as Chief Financial Officer. Mr. Garrett will be base

IRVINE, Calif., Sept. 3, 2019 /PRNewswire/ -- Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company with innovative technologies for the early diagnosis of cancer, today announced that its Liver Cancer detection test has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA). The liquid biopsy bloo

BOTHELL, Wash., Sept. 3, 2019 /PRNewswire/ -- BioLife Solutions

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Inhibrx, Inc. (Inhibrx), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today the completion of the dose escalation portion of its Phase 1 clinical trial of INBRX-109. INBRX-109 is a multivalent agonist of death receptor 5 (DR5) in development

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases, today announced the appointment of Nihar Bhakta, M.D. as Chief Medical Officer.  In his new role, Dr. Bhakta will be responsible for leading and expanding

AUSTIN, Texas, Sept. 3, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 17th Annual Global Healthcare Conference to be held September 9-11, 2019, in

ATLANTA, Sept. 3, 2019 /PRNewswire/ -- MedShape, Inc., the industry leader in orthopedic devices using advanced functional materials, announced today the launch of the DynaNail Mini™ Fusion System. Featuring MedShape's patented superelastic nickel titanium (NiTiNOL) technology, the DynaNail Mini is the first orthopaedic device designed specifically for

LAVAL, Quebec, Sept. 3, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by approximately $200 million through the prepayment of senior secured term loans and the redemption of outstanding senior notes, using cash flow from operations. Bausch Healt

IRVINE, Calif., Sept. 3, 2019 /PRNewswire/ -- To help researchers improve data accuracy and cross-study comparisons, Zymo Research is providing complimentary microbiome standards and controls to researchers worldwide through